Pisa Syndrome and Atypical Antipsychotics [1]

American Journal of Psychiatry

Volumn 161, Issue 2, 2004, Pages 373-

  Duggal, Harpreet S ^a   Sivamony, Swapna ^a   Umapathy, Channamalappa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DIPHENHYDRAMINE; LITHIUM; LORAZEPAM; OLANZAPINE; QUETIAPINE; RISPERIDONE; VENLAFAXINE; NEUROLEPTIC AGENT;

AGED; CASE REPORT; DEPRESSION; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LETTER; PHYSICAL EXAMINATION; PISA SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; SYNDROME; CHEMICALLY INDUCED DISORDER; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; MAJOR DEPRESSION;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CLOZAPINE; DEPRESSIVE DISORDER, MAJOR; DYSTONIA; FEMALE; HUMANS; SYNDROME;

EID: 19244365620     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.161.2.373     Document Type: Letter

References (5)

1. Villarejo A, Camacho A, Garcia-Ramos R, Moreno T, Penas M, Juntas R, Ruiz J: Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol 2003; 26:119-121
2. Kurtz G, Kapfhammer HP, Peuker B: Pisa in clozapine therapy. Nervenarzt 1992; 64:742-746
3. Bruneau MA, Stip E: Metronome or alternating Pisa syndrome: a form of tardive dystonia under clozapine treatment. Int Clin Psychopharmacol 1998; 13:229-232
4. Stubner S, Padberg F, Grohmann R, Hampel H, Hollweg M, Hippius H, Moller HJ, Ruther E: Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry 2000; 61:569-574
5. Suzuki S, Matsuzaka H: Drug-induced Pisa syndrome (pleurothotonus). CNS Drugs 2002; 16:165-174